{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:01:34Z","timestamp":1776438094606,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000039"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000039"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/00169\/2013"],"award-info":[{"award-number":["PD\/00169\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/143038\/2018"],"award-info":[{"award-number":["PD\/BD\/143038\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.nano.2023.102704","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T01:50:09Z","timestamp":1691977809000},"page":"102704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Microfluidic-derived docosahexaenoic acid liposomes for glioblastoma therapy"],"prefix":"10.1016","volume":"53","author":[{"given":"D.","family":"Mendanha","sequence":"first","affiliation":[]},{"given":"S.","family":"Gimondi","sequence":"additional","affiliation":[]},{"given":"B.M.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"H.","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"N.M.","family":"Neves","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nano.2023.102704_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.nano.2023.102704_bb0010","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nano.2023.102704_bb0015","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2147\/CMAR.S186142","article-title":"The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix","volume":"11","author":"Hatoum","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"7","key":"10.1016\/j.nano.2023.102704_bb0020","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","article-title":"Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma","volume":"28","author":"Qazi","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nano.2023.102704_bb0025","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jconrel.2021.07.047","article-title":"Biomimetic and cell-based nanocarriers - new strategies for brain tumor targeting","volume":"337","author":"Mendanha","year":"2021","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.nano.2023.102704_bb0030","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.nano.2023.102704_bb0035","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2023.102704_bb0040","article-title":"Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy","volume":"49","author":"Mendanha","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2023.102704_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2018.05.008","article-title":"Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment","volume":"281","author":"Ganipineni","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2023.102704_bb0050","article-title":"Microfluidic mixing system for precise PLGA-PEG nanoparticles size control","volume":"40","author":"Gimondi","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2023.102704_bb0055","article-title":"Microfluidic-driven mixing of high molecular weight polymeric complexes for precise nanoparticle downsizing","volume":"43","author":"Gimondi","year":"2022","journal-title":"Nanomedicine"},{"issue":"15","key":"10.1016\/j.nano.2023.102704_bb0060","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1021\/acsnano.3c01117","article-title":"Microfluidic devices: a tool for nanoparticle synthesis and performance evaluation","volume":"17","author":"Gimondi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2023.102704_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.addr.2018.03.008","article-title":"Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems","volume":"128","author":"Maeki","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2023.102704_bb0070","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1177\/0148607115595980","article-title":"Functional roles of fatty acids and their effects on human health","volume":"39","author":"Calder","year":"2015","journal-title":"J Parenter Enteral Nutr"},{"issue":"6","key":"10.1016\/j.nano.2023.102704_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10060381","article-title":"Importance of the role of omega-3 and omega-6 polyunsaturated fatty acids in the progression of brain cancer","volume":"10","author":"Montecillo-Aguado","year":"2020","journal-title":"Brain Sci"},{"issue":"10","key":"10.1016\/j.nano.2023.102704_bb0080","doi-asserted-by":"crossref","first-page":"21167","DOI":"10.3390\/ijms141021167","article-title":"Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis","volume":"14","author":"Raphael","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.nano.2023.102704_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3810\/pgm.2009.11.2083","article-title":"Understanding omega-3 polyunsaturated fatty acids","volume":"121","author":"Calder","year":"2009","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.nano.2023.102704_bb0090","first-page":"420","article-title":"Essential fatty acids: biochemistry, physiology and pathology","volume":"1","author":"Das","year":"2006","journal-title":"Biotechnol J Healthc Nutr Technol"},{"issue":"1","key":"10.1016\/j.nano.2023.102704_bb0095","first-page":"239","article-title":"Omega3-polyunsaturated fatty acids induce cell death through apoptosis and autophagy in glioblastoma cells: in vitro and in vivo","volume":"39","author":"Kim","year":"2018","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.nano.2023.102704_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/nu10040454","article-title":"Omega-3 and omega-6 fatty acids modulate conventional and atypical protein kinase C activities in a brain fatty acid binding protein dependent manner in glioblastoma multiforme","volume":"10","author":"Elsherbiny","year":"2018","journal-title":"Nutrients"},{"issue":"47","key":"10.1016\/j.nano.2023.102704_bb0105","doi-asserted-by":"crossref","first-page":"37005","DOI":"10.1074\/jbc.M110.170076","article-title":"Brain fatty acid-binding protein and omega-3\/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration","volume":"285","author":"Mita","year":"2010","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.nano.2023.102704_bb0110","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2174\/1389200221666210101115148","article-title":"Nanostructured therapeutic systems of PUFAs for the treatment of glioblastoma multiforme","volume":"22","author":"Saad","year":"2021","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.nano.2023.102704_bb0115","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2147\/IDR.S315727","article-title":"Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy, and safety","volume":"14","author":"Mascellino","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.nano.2023.102704_bb0120","doi-asserted-by":"crossref","first-page":"25876","DOI":"10.1038\/srep25876","article-title":"Liposome production by microfluidics: potential and limiting factors","volume":"6","author":"Carugo","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.nano.2023.102704_bb0125","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1021\/nn901676x","article-title":"Microfluidic mixing and the formation of nanoscale lipid vesicles","volume":"4","author":"Jahn","year":"2010","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.nano.2023.102704_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061259","article-title":"Fabrication of doxorubicin-loaded lipid-based nanocarriers by microfluidic rapid mixing","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.nano.2023.102704_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122320","article-title":"Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy","volume":"628","author":"Jaradat","year":"2022","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.nano.2023.102704_bb0140","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1038\/s41467-022-34750-3","article-title":"Microfluidic vortex focusing for high throughput synthesis of size-tunable liposomes","volume":"13","author":"Han","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2023.102704_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.colsurfb.2016.09.016","article-title":"Microfluidic synthesis of multifunctional liposomes for tumour targeting","volume":"148","author":"Ran","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"51","key":"10.1016\/j.nano.2023.102704_bb0150","doi-asserted-by":"crossref","first-page":"23032","DOI":"10.1021\/acs.iecr.9b04079","article-title":"Continuous production of the nanoscale liposome in a double flow-focusing microfluidic device","volume":"58","author":"Aghaei","year":"2019","journal-title":"Ind Eng Chem Res"},{"issue":"11","key":"10.1016\/j.nano.2023.102704_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187962","article-title":"Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers","volume":"12","author":"Maeki","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.nano.2023.102704_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.nano.2023.102704_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.nano.2023.102704_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s12645-019-0055-y","article-title":"Nanomedicine review: clinical developments in liposomal applications","volume":"10","author":"Beltr\u00e1n-Gracia","year":"2019","journal-title":"Cancer Nanotechnol"},{"key":"10.1016\/j.nano.2023.102704_bb0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2018.02.015","article-title":"Immunoliposomes in clinical oncology: state of the art and future perspectives","volume":"275","author":"Merino","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2023.102704_bb0180","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2147\/IJN.S197499","article-title":"Nanomedicine-based formulations containing omega-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases","volume":"14","author":"Serini","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2023.102704_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2016.03.035","article-title":"A novel biologically active acid stable liposomal formulation of docosahexaenoic acid in human breast cancer cell lines","volume":"252","author":"Skibinski","year":"2016","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.nano.2023.102704_bb0190","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2174\/1871520616666160817143656","article-title":"Docetaxel-loaded bovine serum albumin nanoparticles conjugated docosahexaenoic acid for inhibiting lung cancer metastasis to bone","volume":"17","author":"Zu","year":"2017","journal-title":"Anti-Cancer Agents Med Chem"},{"issue":"8","key":"10.1016\/j.nano.2023.102704_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17081257","article-title":"Docosahexaenoic acid induces oxidative DNA damage and apoptosis, and enhances the chemosensitivity of cancer cells","volume":"17","author":"Song","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.nano.2023.102704_bb0200","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/01635581.2016.1142581","article-title":"Docosahexaenoic acid induces growth suppression on epithelial ovarian cancer cells more effectively than eicosapentaenoic acid","volume":"68","author":"Wan","year":"2016","journal-title":"Nutr Cancer"},{"issue":"6","key":"10.1016\/j.nano.2023.102704_bb0205","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/jcp.25217","article-title":"Effect of docosahexaenoic acid on cell cycle pathways in breast cell lines with different transformation degree","volume":"231","author":"Rescigno","year":"2016","journal-title":"J Cell Physiol"},{"issue":"8","key":"10.1016\/j.nano.2023.102704_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081784","article-title":"A critical review on the effect of docosahexaenoic acid (DHA) on cancer cell cycle progression","volume":"18","author":"Newell","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nano.2023.102704_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/cdd.2012.102","article-title":"The critical role of catalase in prooxidant and antioxidant function of p53","volume":"20","author":"Kang","year":"2013","journal-title":"Cell Death Differ"},{"issue":"5","key":"10.1016\/j.nano.2023.102704_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051562","article-title":"Heme oxygenase-1 in central nervous system malignancies","volume":"9","author":"Sferrazzo","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.nano.2023.102704_bb0225","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.freeradbiomed.2017.09.002","article-title":"Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma","volume":"112","author":"Ou","year":"2017","journal-title":"Free Radic Biol Med"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963423000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963423000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:19:23Z","timestamp":1761549563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963423000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":45,"alternative-id":["S1549963423000552"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2023.102704","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microfluidic-derived docosahexaenoic acid liposomes for glioblastoma therapy","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2023.102704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102704"}}